Advertisement

Topics

QuantuMDx Group Company Profile

06:24 EST 25th November 2017 | BioPortfolio

QuantuMDx Group is a U.K. based nanomedtech company founded by Elaine Warburton, an experienced healthcare chief executive and Jonathan O’Halloran, a molecular biologist and the inventor of QuantuMDx Group’s technology. QuantuMDx Group is developing and commercializing affordable handheld sample-to-result diagnostic and genomic sequencing technologies based around a nanowire biosensor and innovative microfluidics. The company has offices in the U.K. and U.S.A.. Additional information on QuantuMDx Group can be found at www.quantumdx.com


News Articles [272 Associated News Articles listed on BioPortfolio]

Bionow are delighted to announce the shortlisted nominees for the 2013 Biomedical Awards

The winners for each category will be announced at the 2013 Biomedical Awards which is taking place on Thursday 28 February at the BALTIC Centre for Contemporary Art, on Gateshead Quays. Hosted by ...

QuantuMDx’s CEO receives OBE for services to health innovation

QuantuMDx Group’s CEO and Co-Founder Elaine Warburton has been honoured in the Queen’s New Year’s Honours list 2014. Elaine will become Officer of the Order of the British Empire (OB...

QuantuMDx recognised for Medical & Life Sciences innovation at Made in the North East Awards

QuantuMDx Group Limited, a pioneering biotech company based at The Centre for Life in Newcastle upon Tyne, was awarded the Insider’s ‘Made in the North East’ Life Sciences trophy in ...

QuantuMDx closes $8.42m investment round for prototyping handheld MDx device

Handheld molecular diagnostics device pioneer QuantuMDx Group announced it had closed an $8.42m funding round it syndicated with philanthropist private investors and the University of Newcastle upon T...

QuantuMDx launches crowdfunding campaign to help eliminate malaria with handheld lab

On February 12th, QuantuMDx will launch an Indiegogo crowdfunding campaign to support the humanitarian health challenge to eradicate malaria by further developing and trialling their 15-minute malaria...

QuantuMDx Announce Prototype Handheld Lab For 15 minute DNA-based Diagnosis

At the TEDMED 2014 conference, medical device developers QuantuMDx Group announced the successful production of their first fully-integrated sample-to-result working prototype of Q-POC™, a handh...

QuantuMDx awarded £1m grant to develop rapid multi-drug resistant TB test for their smartphone-like device

British biotech QuantuMDx has been awarded a UK government’s Technology Strategy Board (TSB) grant to develop Q-TB™, a rapid and cheap test that will analyse sputum samples at the patient&...

QuantuMDx Group Ltd Medical Equipment Deals and Alliances Profile [Report Updated: 12102017] Prices from USD $250

SummaryQuantuMDx Group Ltd QuantuMDx is a medical device company that develops hand held and portable diagnostic, genomic sequencing and proteomic platforms. The company's products comprise QPOC is a ...

PubMed Articles [1805 Associated PubMed Articles listed on BioPortfolio]

Transcanalicular laser-assisted dacryocystorhinostomy with diode laser.

This article compares the efficacy of transcanalicular laser assisted dacryocystorhinostomy (TL DCR) with conventional external dacryocystorhinostomy (Ex DCR). All patients were randomly divided into ...

Thirty first annual symposium on etiology, pathogenesis, and treatment of Parkinson disease and other movement disorders: Presented by the Parkinson study group, huntington study group, dystonia study group, tourette syndrome study group, cooperative ataxia group, and tremor research group.

Protective effects of Tempol in an experimental ovarian ischemia-reperfusion injury model in female Wistar Albino rats.

The aim of this study was to investigate the antioxidant effects of tempol on ovarian ischemia-reperfusion injury in rats. Forty female Wistar albino rats were randomly divided into five groups: Group...

Effects of leptin on femoral fracture in rats.

In this study, our objective was to evaluate effects of leptin on fracture healing in rats. Seventy two male Sprague-Dawley (SD) rats were randomized into 3 groups. Standardized femoral fractures were...

Keeping up appearances: Strategic information exchange by disidentified group members.

Information exchange is a crucial process in groups, but to date, no one has systematically examined how a group member's relationship with a group can undermine this process. The current research exa...

Clinical Trials [3256 Associated Clinical Trials listed on BioPortfolio]

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Technical Development of Multi-Parametric Renocerebral MRI

The purpose of the study is to investigate the associations of the age-related changes in the brain, kidneys and cognitive performance in healthy adults by utilizing multiple anatomic and ...

Electro-acupuncture and Flumazenil's Effect on Sedation

Object: To explore the mechanism of the electro-acupuncture (EA) induced sedation effect in general anaesthesia through investigating the role of the Benzodiazepines-GABA system. Method: ...

The Effect of Rhubarb on Sepsis and Post-traumatic Gastrointestinal Function Failure

Random grouping by computer, divided into two groups, a group of rhubarb treatment group, another group for the placebo group.

Does Cognitive Rehabilitation Demonstrate Benefits in the Group Setting With People Whom Have Experienced Brain Injury?

The purpose of this study is to determine whether there is benefit from providing cognitive rehabilitation in the group setting. Several standardized tools will be used to measure progres...

Companies [1578 Associated Companies listed on BioPortfolio]

QuantuMDx Group

QuantuMDx Group is a U.K. based nanomedtech company founded by Elaine Warburton, an experienced healthcare chief executive and Jonathan O’Halloran, a molecular biologist and ...

W2 Group, Inc.

W2 Group is a global marketing services ecosystem that helps CMOs in their new role as builders of communities and content aggregators. W2 Group companies, including Digital ...

PharmEvo (Pvt.) Ltd.

PharmEvo is backed by a reputable corporate group with a history of successful business ventures spread over 30 years. The group made its debut in 1971, with the sales and marketing of prestigious bra...

ACE Group

Celebrating 25 years of insuring progress, the ACE Group is a global leader in insurance and reinsurance serving a diverse group of clients. Headed by ACE Limited (NYSE:ACE), a co...

Man Group plc

The Man Group has its origins over 200 years ago in a broking business founded by James Man and was floated on the London Stock Exchange in 1994. Man Group plc trades on the London Stock Exchange (EMG...

More Information about "QuantuMDx Group" on BioPortfolio

We have published hundreds of QuantuMDx Group news stories on BioPortfolio along with dozens of QuantuMDx Group Clinical Trials and PubMed Articles about QuantuMDx Group for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of QuantuMDx Group Companies in our database. You can also find out about relevant QuantuMDx Group Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...


Corporate Database Quicklinks



Searches Linking to this Company Record